The Buclizine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Buclizine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Antiallergic Agent accounting for % of the Buclizine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Hospital segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Buclizine include Stuart Pharmaceuticals, Laboratorios Rocnarf, UCB, Mankind Pharma, and Johnson and Johnson, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Buclizine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Hospital
Drug Store
Market segment by Application can be divided into
Antiallergic Agent
Histamine H₁-Receptor Antagonist
The key market players for global Buclizine market are listed below:
Stuart Pharmaceuticals
Laboratorios Rocnarf
UCB
Mankind Pharma
Johnson and Johnson
Meider Pharma
Sanofi
MK Pharma
HUA Shin Chemical Pharmaceutical
Peili Pharmaceutical
Pfizer
Sinphar
Al Pharm
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Buclizine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Buclizine, with price, sales, revenue and global market share of Buclizine from 2019 to 2022.
Chapter 3, the Buclizine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Buclizine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Buclizine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Buclizine.
Chapter 13, 14, and 15, to describe Buclizine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Buclizine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Buclizine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Hospital
1.2.3 Drug Store
1.3 Market Analysis by Application
1.3.1 Overview: Global Buclizine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Antiallergic Agent
1.3.3 Histamine H₁-Receptor Antagonist
1.4 Global Buclizine Market Size & Forecast
1.4.1 Global Buclizine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Buclizine Sales in Volume (2017-2028)
1.4.3 Global Buclizine Price (2017-2028)
1.5 Global Buclizine Production Capacity Analysis
1.5.1 Global Buclizine Total Production Capacity (2017-2028)
1.5.2 Global Buclizine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Buclizine Market Drivers
1.6.2 Buclizine Market Restraints
1.6.3 Buclizine Trends Analysis
2 Manufacturers Profiles
2.1 Stuart Pharmaceuticals
2.1.1 Stuart Pharmaceuticals Details
2.1.2 Stuart Pharmaceuticals Major Business
2.1.3 Stuart Pharmaceuticals Buclizine Product and Services
2.1.4 Stuart Pharmaceuticals Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Laboratorios Rocnarf
2.2.1 Laboratorios Rocnarf Details
2.2.2 Laboratorios Rocnarf Major Business
2.2.3 Laboratorios Rocnarf Buclizine Product and Services
2.2.4 Laboratorios Rocnarf Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 UCB
2.3.1 UCB Details
2.3.2 UCB Major Business
2.3.3 UCB Buclizine Product and Services
2.3.4 UCB Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Mankind Pharma
2.4.1 Mankind Pharma Details
2.4.2 Mankind Pharma Major Business
2.4.3 Mankind Pharma Buclizine Product and Services
2.4.4 Mankind Pharma Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Johnson and Johnson
2.5.1 Johnson and Johnson Details
2.5.2 Johnson and Johnson Major Business
2.5.3 Johnson and Johnson Buclizine Product and Services
2.5.4 Johnson and Johnson Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Meider Pharma
2.6.1 Meider Pharma Details
2.6.2 Meider Pharma Major Business
2.6.3 Meider Pharma Buclizine Product and Services
2.6.4 Meider Pharma Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Buclizine Product and Services
2.7.4 Sanofi Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 MK Pharma
2.8.1 MK Pharma Details
2.8.2 MK Pharma Major Business
2.8.3 MK Pharma Buclizine Product and Services
2.8.4 MK Pharma Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 HUA Shin Chemical Pharmaceutical
2.9.1 HUA Shin Chemical Pharmaceutical Details
2.9.2 HUA Shin Chemical Pharmaceutical Major Business
2.9.3 HUA Shin Chemical Pharmaceutical Buclizine Product and Services
2.9.4 HUA Shin Chemical Pharmaceutical Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Peili Pharmaceutical
2.10.1 Peili Pharmaceutical Details
2.10.2 Peili Pharmaceutical Major Business
2.10.3 Peili Pharmaceutical Buclizine Product and Services
2.10.4 Peili Pharmaceutical Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Pfizer
2.11.1 Pfizer Details
2.11.2 Pfizer Major Business
2.11.3 Pfizer Buclizine Product and Services
2.11.4 Pfizer Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Sinphar
2.12.1 Sinphar Details
2.12.2 Sinphar Major Business
2.12.3 Sinphar Buclizine Product and Services
2.12.4 Sinphar Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Al Pharm
2.13.1 Al Pharm Details
2.13.2 Al Pharm Major Business
2.13.3 Al Pharm Buclizine Product and Services
2.13.4 Al Pharm Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Buclizine Breakdown Data by Manufacturer
3.1 Global Buclizine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Buclizine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Buclizine
3.4 Market Concentration Rate
3.4.1 Top 3 Buclizine Manufacturer Market Share in 2021
3.4.2 Top 6 Buclizine Manufacturer Market Share in 2021
3.5 Global Buclizine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Buclizine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Buclizine Market Size by Region
4.1.1 Global Buclizine Sales in Volume by Region (2017-2028)
4.1.2 Global Buclizine Revenue by Region (2017-2028)
4.2 North America Buclizine Revenue (2017-2028)
4.3 Europe Buclizine Revenue (2017-2028)
4.4 Asia-Pacific Buclizine Revenue (2017-2028)
4.5 South America Buclizine Revenue (2017-2028)
4.6 Middle East and Africa Buclizine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Buclizine Sales in Volume by Type (2017-2028)
5.2 Global Buclizine Revenue by Type (2017-2028)
5.3 Global Buclizine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Buclizine Sales in Volume by Application (2017-2028)
6.2 Global Buclizine Revenue by Application (2017-2028)
6.3 Global Buclizine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Buclizine Sales by Type (2017-2028)
7.2 North America Buclizine Sales by Application (2017-2028)
7.3 North America Buclizine Market Size by Country
7.3.1 North America Buclizine Sales in Volume by Country (2017-2028)
7.3.2 North America Buclizine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Buclizine Sales by Type (2017-2028)
8.2 Europe Buclizine Sales by Application (2017-2028)
8.3 Europe Buclizine Market Size by Country
8.3.1 Europe Buclizine Sales in Volume by Country (2017-2028)
8.3.2 Europe Buclizine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Buclizine Sales by Type (2017-2028)
9.2 Asia-Pacific Buclizine Sales by Application (2017-2028)
9.3 Asia-Pacific Buclizine Market Size by Region
9.3.1 Asia-Pacific Buclizine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Buclizine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Buclizine Sales by Type (2017-2028)
10.2 South America Buclizine Sales by Application (2017-2028)
10.3 South America Buclizine Market Size by Country
10.3.1 South America Buclizine Sales in Volume by Country (2017-2028)
10.3.2 South America Buclizine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Buclizine Sales by Type (2017-2028)
11.2 Middle East & Africa Buclizine Sales by Application (2017-2028)
11.3 Middle East & Africa Buclizine Market Size by Country
11.3.1 Middle East & Africa Buclizine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Buclizine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Buclizine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Buclizine
12.3 Buclizine Production Process
12.4 Buclizine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Buclizine Typical Distributors
13.3 Buclizine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Buclizine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Buclizine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Stuart Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Stuart Pharmaceuticals Major Business
Table 5. Stuart Pharmaceuticals Buclizine Product and Services
Table 6. Stuart Pharmaceuticals Buclizine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Laboratorios Rocnarf Basic Information, Manufacturing Base and Competitors
Table 8. Laboratorios Rocnarf Major Business
Table 9. Laboratorios Rocnarf Buclizine Product and Services
Table 10. Laboratorios Rocnarf Buclizine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. UCB Basic Information, Manufacturing Base and Competitors
Table 12. UCB Major Business
Table 13. UCB Buclizine Product and Services
Table 14. UCB Buclizine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Mankind Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Mankind Pharma Major Business
Table 17. Mankind Pharma Buclizine Product and Services
Table 18. Mankind Pharma Buclizine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 20. Johnson and Johnson Major Business
Table 21. Johnson and Johnson Buclizine Product and Services
Table 22. Johnson and Johnson Buclizine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Meider Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Meider Pharma Major Business
Table 25. Meider Pharma Buclizine Product and Services
Table 26. Meider Pharma Buclizine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Sanofi Basic Information, Manufacturing Base and Competitors
Table 28. Sanofi Major Business
Table 29. Sanofi Buclizine Product and Services
Table 30. Sanofi Buclizine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. MK Pharma Basic Information, Manufacturing Base and Competitors
Table 32. MK Pharma Major Business
Table 33. MK Pharma Buclizine Product and Services
Table 34. MK Pharma Buclizine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. HUA Shin Chemical Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 36. HUA Shin Chemical Pharmaceutical Major Business
Table 37. HUA Shin Chemical Pharmaceutical Buclizine Product and Services
Table 38. HUA Shin Chemical Pharmaceutical Buclizine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Peili Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Peili Pharmaceutical Major Business
Table 41. Peili Pharmaceutical Buclizine Product and Services
Table 42. Peili Pharmaceutical Buclizine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Pfizer Basic Information, Manufacturing Base and Competitors
Table 44. Pfizer Major Business
Table 45. Pfizer Buclizine Product and Services
Table 46. Pfizer Buclizine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Sinphar Basic Information, Manufacturing Base and Competitors
Table 48. Sinphar Major Business
Table 49. Sinphar Buclizine Product and Services
Table 50. Sinphar Buclizine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Al Pharm Basic Information, Manufacturing Base and Competitors
Table 52. Al Pharm Major Business
Table 53. Al Pharm Buclizine Product and Services
Table 54. Al Pharm Buclizine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Global Buclizine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 56. Global Buclizine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 57. Market Position of Manufacturers in Buclizine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 58. Global Buclizine Production Capacity by Company, (K Units): 2020 VS 2021
Table 59. Head Office and Buclizine Production Site of Key Manufacturer
Table 60. Buclizine New Entrant and Capacity Expansion Plans
Table 61. Buclizine Mergers & Acquisitions in the Past Five Years
Table 62. Global Buclizine Sales by Region (2017-2022) & (K Units)
Table 63. Global Buclizine Sales by Region (2023-2028) & (K Units)
Table 64. Global Buclizine Revenue by Region (2017-2022) & (USD Million)
Table 65. Global Buclizine Revenue by Region (2023-2028) & (USD Million)
Table 66. Global Buclizine Sales by Type (2017-2022) & (K Units)
Table 67. Global Buclizine Sales by Type (2023-2028) & (K Units)
Table 68. Global Buclizine Revenue by Type (2017-2022) & (USD Million)
Table 69. Global Buclizine Revenue by Type (2023-2028) & (USD Million)
Table 70. Global Buclizine Price by Type (2017-2022) & (US$/Unit)
Table 71. Global Buclizine Price by Type (2023-2028) & (US$/Unit)
Table 72. Global Buclizine Sales by Application (2017-2022) & (K Units)
Table 73. Global Buclizine Sales by Application (2023-2028) & (K Units)
Table 74. Global Buclizine Revenue by Application (2017-2022) & (USD Million)
Table 75. Global Buclizine Revenue by Application (2023-2028) & (USD Million)
Table 76. Global Buclizine Price by Application (2017-2022) & (US$/Unit)
Table 77. Global Buclizine Price by Application (2023-2028) & (US$/Unit)
Table 78. North America Buclizine Sales by Country (2017-2022) & (K Units)
Table 79. North America Buclizine Sales by Country (2023-2028) & (K Units)
Table 80. North America Buclizine Revenue by Country (2017-2022) & (USD Million)
Table 81. North America Buclizine Revenue by Country (2023-2028) & (USD Million)
Table 82. North America Buclizine Sales by Type (2017-2022) & (K Units)
Table 83. North America Buclizine Sales by Type (2023-2028) & (K Units)
Table 84. North America Buclizine Sales by Application (2017-2022) & (K Units)
Table 85. North America Buclizine Sales by Application (2023-2028) & (K Units)
Table 86. Europe Buclizine Sales by Country (2017-2022) & (K Units)
Table 87. Europe Buclizine Sales by Country (2023-2028) & (K Units)
Table 88. Europe Buclizine Revenue by Country (2017-2022) & (USD Million)
Table 89. Europe Buclizine Revenue by Country (2023-2028) & (USD Million)
Table 90. Europe Buclizine Sales by Type (2017-2022) & (K Units)
Table 91. Europe Buclizine Sales by Type (2023-2028) & (K Units)
Table 92. Europe Buclizine Sales by Application (2017-2022) & (K Units)
Table 93. Europe Buclizine Sales by Application (2023-2028) & (K Units)
Table 94. Asia-Pacific Buclizine Sales by Region (2017-2022) & (K Units)
Table 95. Asia-Pacific Buclizine Sales by Region (2023-2028) & (K Units)
Table 96. Asia-Pacific Buclizine Revenue by Region (2017-2022) & (USD Million)
Table 97. Asia-Pacific Buclizine Revenue by Region (2023-2028) & (USD Million)
Table 98. Asia-Pacific Buclizine Sales by Type (2017-2022) & (K Units)
Table 99. Asia-Pacific Buclizine Sales by Type (2023-2028) & (K Units)
Table 100. Asia-Pacific Buclizine Sales by Application (2017-2022) & (K Units)
Table 101. Asia-Pacific Buclizine Sales by Application (2023-2028) & (K Units)
Table 102. South America Buclizine Sales by Country (2017-2022) & (K Units)
Table 103. South America Buclizine Sales by Country (2023-2028) & (K Units)
Table 104. South America Buclizine Revenue by Country (2017-2022) & (USD Million)
Table 105. South America Buclizine Revenue by Country (2023-2028) & (USD Million)
Table 106. South America Buclizine Sales by Type (2017-2022) & (K Units)
Table 107. South America Buclizine Sales by Type (2023-2028) & (K Units)
Table 108. South America Buclizine Sales by Application (2017-2022) & (K Units)
Table 109. South America Buclizine Sales by Application (2023-2028) & (K Units)
Table 110. Middle East & Africa Buclizine Sales by Region (2017-2022) & (K Units)
Table 111. Middle East & Africa Buclizine Sales by Region (2023-2028) & (K Units)
Table 112. Middle East & Africa Buclizine Revenue by Region (2017-2022) & (USD Million)
Table 113. Middle East & Africa Buclizine Revenue by Region (2023-2028) & (USD Million)
Table 114. Middle East & Africa Buclizine Sales by Type (2017-2022) & (K Units)
Table 115. Middle East & Africa Buclizine Sales by Type (2023-2028) & (K Units)
Table 116. Middle East & Africa Buclizine Sales by Application (2017-2022) & (K Units)
Table 117. Middle East & Africa Buclizine Sales by Application (2023-2028) & (K Units)
Table 118. Buclizine Raw Material
Table 119. Key Manufacturers of Buclizine Raw Materials
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Buclizine Typical Distributors
Table 123. Buclizine Typical Customers
List of Figures
Figure 1. Buclizine Picture
Figure 2. Global Buclizine Revenue Market Share by Type in 2021
Figure 3. Hospital
Figure 4. Drug Store
Figure 5. Global Buclizine Revenue Market Share by Application in 2021
Figure 6. Antiallergic Agent
Figure 7. Histamine H₁-Receptor Antagonist
Figure 8. Global Buclizine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Buclizine Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Buclizine Sales (2017-2028) & (K Units)
Figure 11. Global Buclizine Price (2017-2028) & (US$/Unit)
Figure 12. Global Buclizine Production Capacity (2017-2028) & (K Units)
Figure 13. Global Buclizine Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Buclizine Market Drivers
Figure 15. Buclizine Market Restraints
Figure 16. Buclizine Market Trends
Figure 17. Global Buclizine Sales Market Share by Manufacturer in 2021
Figure 18. Global Buclizine Revenue Market Share by Manufacturer in 2021
Figure 19. Buclizine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Buclizine Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Buclizine Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Buclizine Sales Market Share by Region (2017-2028)
Figure 23. Global Buclizine Revenue Market Share by Region (2017-2028)
Figure 24. North America Buclizine Revenue (2017-2028) & (USD Million)
Figure 25. Europe Buclizine Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Buclizine Revenue (2017-2028) & (USD Million)
Figure 27. South America Buclizine Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Buclizine Revenue (2017-2028) & (USD Million)
Figure 29. Global Buclizine Sales Market Share by Type (2017-2028)
Figure 30. Global Buclizine Revenue Market Share by Type (2017-2028)
Figure 31. Global Buclizine Price by Type (2017-2028) & (US$/Unit)
Figure 32. Global Buclizine Sales Market Share by Application (2017-2028)
Figure 33. Global Buclizine Revenue Market Share by Application (2017-2028)
Figure 34. Global Buclizine Price by Application (2017-2028) & (US$/Unit)
Figure 35. North America Buclizine Sales Market Share by Type (2017-2028)
Figure 36. North America Buclizine Sales Market Share by Application (2017-2028)
Figure 37. North America Buclizine Sales Market Share by Country (2017-2028)
Figure 38. North America Buclizine Revenue Market Share by Country (2017-2028)
Figure 39. United States Buclizine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Buclizine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Buclizine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Buclizine Sales Market Share by Type (2017-2028)
Figure 43. Europe Buclizine Sales Market Share by Application (2017-2028)
Figure 44. Europe Buclizine Sales Market Share by Country (2017-2028)
Figure 45. Europe Buclizine Revenue Market Share by Country (2017-2028)
Figure 46. Germany Buclizine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Buclizine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Buclizine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Buclizine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Buclizine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Buclizine Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Buclizine Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Buclizine Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Buclizine Revenue Market Share by Region (2017-2028)
Figure 55. China Buclizine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Buclizine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Buclizine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Buclizine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Buclizine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Buclizine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Buclizine Sales Market Share by Type (2017-2028)
Figure 62. South America Buclizine Sales Market Share by Application (2017-2028)
Figure 63. South America Buclizine Sales Market Share by Country (2017-2028)
Figure 64. South America Buclizine Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Buclizine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Buclizine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Buclizine Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Buclizine Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Buclizine Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Buclizine Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Buclizine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Buclizine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Buclizine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Buclizine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Buclizine in 2021
Figure 76. Manufacturing Process Analysis of Buclizine
Figure 77. Buclizine Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source